Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of UroGen Pharma Ltd (NASDAQ: URGN) was $19.22 for the day, up 1.69% from the previous closing price of $18.9. In other words, the price has increased by $1.69 from its previous closing price. On the day, 1.16 million shares were traded. URGN stock price reached its highest trading level at $19.74 during the session, while it also had its lowest trading level at $18.89.
Ratios:
Our analysis of URGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.47 and its Current Ratio is at 5.65.
On April 16, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $23.Scotiabank initiated its Sector Outperform rating on April 16, 2025, with a $23 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 28 ’25 when Smith Jason Drew sold 7,522 shares for $19.14 per share. The transaction valued at 143,971 led to the insider holds 41,492 shares of the business.
Schoenberg Mark sold 5,149 shares of URGN for $98,552 on Jul 28 ’25. The Chief Medical Officer now owns 158,229 shares after completing the transaction at $19.14 per share. On Jul 28 ’25, another insider, Schoenberg Mark, who serves as the Officer of the company, bought 5,149 shares for $18.95 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, URGN now has a Market Capitalization of 887988928 and an Enterprise Value of 816658240. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.67. Its current Enterprise Value per Revenue stands at 8.889 whereas that against EBITDA is -7.663.
Stock Price History:
The Beta on a monthly basis for URGN is 1.14, which has changed by 0.21491778 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, URGN has reached a high of $19.35, while it has fallen to a 52-week low of $3.42. The 50-Day Moving Average of the stock is 64.79%, while the 200-Day Moving Average is calculated to be 71.50%.
Shares Statistics:
URGN traded an average of 3.11M shares per day over the past three months and 1590760 shares per day over the past ten days. A total of 46.10M shares are outstanding, with a floating share count of 39.70M. Insiders hold about 14.08% of the company’s shares, while institutions hold 96.73% stake in the company. Shares short for URGN as of 1752537600 were 7293235 with a Short Ratio of 2.35, compared to 1749772800 on 6125129. Therefore, it implies a Short% of Shares Outstanding of 7293235 and a Short% of Float of 16.03.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
